Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV)

INTRODUCTION: Clinical trials have demonstrated the efficacy of all-oral direct-acting antiviral (DAA) regimens in the treatment of patients infected with hepatitis C virus (HCV). This study assessed real-world effectiveness of two recently approved regimens; paritaprevir/ritonavir/ombitasvir; dasab...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, David R., Pedrosa, Marcos C., Manthena, Shivaji R., Patel, Nikil, Marx, Steven E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662718/
https://www.ncbi.nlm.nih.gov/pubmed/26538232
http://dx.doi.org/10.1007/s12325-015-0258-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662718/
https://www.ncbi.nlm.nih.gov/pubmed/26538232
http://dx.doi.org/10.1007/s12325-015-0258-5

Ejemplares similares